Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Smallpox Vaccine Adverse Event Treatment Will Be Made Under CDC Contract

Executive Summary

The Centers for Disease Control & Prevention is in the final stages of negotiating a contract for production of 30,000 vaccinia immune globulin intravenous treatments

You may also be interested in...



Smallpox Sequela FDA Draft Guidance Recommends Data Collection Systems

An FDA draft guidance on developing drugs to treat complications associated with smallpox vaccination lists data collection recommendations for pre-terrorism events, post-terrorism events and post-approval

Smallpox Sequela FDA Draft Guidance Recommends Data Collection Systems

An FDA draft guidance on developing drugs to treat complications associated with smallpox vaccination lists data collection recommendations for pre-terrorism events, post-terrorism events and post-approval

Dryvax Likely Candidate For Smallpox Immunization Of First Responders

The Centers for Disease Control & Prevention is likely to recommend that a subset of first responders receive Wyeth's smallpox vaccine Dryvax

Latest Headlines
See All
UsernamePublicRestriction

Register

PS040101

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel